These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 68017)

  • 1. Immunogenicity of solubilized tumor antigen extracted from P1798 murine lymphoma cells or isolated from tumor-bearer ascites fluid and reactivity with anti-thy-1.2 antiserum.
    Gordon WC; Baechtel FS; Goetz G; Prager MD
    Int J Cancer; 1977 May; 19(5):692-9. PubMed ID: 68017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
    Prager MD; Granatek CH; Ludden CM
    Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-thymocyte autoimmunity in BALB/C mice accompanying immunization to a syngeneic lymphoma.
    Baechtel FS; Prager MD
    J Immunol; 1977 Jan; 118(1):175-9. PubMed ID: 299754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of modified tumor cells in syngenic hosts.
    Prager MD; Gordon WC; Baechtel FS
    Ann N Y Acad Sci; 1976; 276():61-74. PubMed ID: 1071980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of a tumour specific transplantation-type antigen from the ascitic fluid of mice bearing a syngeneic lymphoma.
    Wolf A; Steele KA
    Br J Cancer; 1975 Jun; 31(6):684-8. PubMed ID: 1174446
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of autoanti-Thi-1 antibody in the sera of BALB/c mice immune to P1798 lymphoma.
    Baechtel FS; Prager MD; Vitetta ES
    Eur J Immunol; 1979 Jun; 9(6):450-4. PubMed ID: 499326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.
    Hilgers J; Haverman J; Nusse R; van Blitterswijk WJ; Cleton FJ; Hageman PC; van Nie P; Calafat J
    J Natl Cancer Inst; 1975 Jun; 54(6):1323-33. PubMed ID: 166186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation in sera by radioimmunoassay of a specific membrane antigen associated with a murine lymphoma.
    Wolf A; Steele KA; Alexander P
    Br J Cancer; 1976 Feb; 33(2):144-53. PubMed ID: 1259913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.
    Mackel AM; Craddock GR; Warr GW; DeLuca D; Marchalonis JJ
    J Immunol; 1983 Sep; 131(3):1582-90. PubMed ID: 6350458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous antiserum to a subpopulation of thymocytes and lymphomas in rats.
    Moriuchi T; Kasai M; Kobayashi H
    Gan; 1979 Dec; 70(6):825-8. PubMed ID: 317055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural anti-tumor serum reactivity in BALB/c mice. I. Characterization and interference with tumor growth.
    Ménard S; Colnaghi MI; Porta GD
    Int J Cancer; 1977 Feb; 19(2):267-74. PubMed ID: 300077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced response to chemoimmunotherapy and immunoprophylaxis with the use of tumor-associated antigens with a lipophilic agent.
    Prager MD; Gordon WC
    Cancer Res; 1978 Jul; 38(7):2052-7. PubMed ID: 657141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.
    Biddison WE; Palmer JC
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):329-33. PubMed ID: 402006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theta antigen and immunogolbulin on a tissue-cultured mouse lymphoma.
    Boylston AW
    Immunology; 1973 May; 24(5):851-7. PubMed ID: 4541405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific tumoricidal activity of cytotoxic macrophages and cytotoxic lymphocytes.
    Dullens HF; Schakenraad S; Oostdijk A; Vuist W; Van der Maas M; Den Otter W
    Cancer Immunol Immunother; 1986; 22(2):100-6. PubMed ID: 3487380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface receptors involved in the attachment of murine cytotoxic T lymphocytes to target cells - a study with xenoantisera to T-cell antigens.
    Rabinowitz R; Levy J; Schlesinger M
    Thymus; 1983 Apr; 5(3-4):127-39. PubMed ID: 6603681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific cytostatic effect of lymph node cells from normal and T cell-deficient mice on syngeneic tumor target cells in vitro and its specific abrogation by body fluids from syngeneic tumor-bearing mice.
    Chia E; Festenstein H
    Eur J Immunol; 1973 Aug; 3(8):483-7. PubMed ID: 4543175
    [No Abstract]   [Full Text] [Related]  

  • 20. Absence in glucocorticoid-resistant mouse lymphoma P1798 of a glucocorticoid receptor domain responsible for biological effects.
    Okret S; Stevens YW; Carlstedt-Duke J; Wrange O; Gustafsson JA; Stevens J
    Cancer Res; 1983 Jul; 43(7):3127-31. PubMed ID: 6189592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.